The VRML chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the VRML chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The VRML stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View VRML Detailed Price Forecast - CNN Money||View VRML Detailed Summary - Google Finance|
|View VRML Detailed Summary - Yahoo! Finance||View VRML Stock Research & Analysis - Zacks.com|
|View VRML Trends & Analysis - Trade-Ideas||View VRML Major Holders - Barrons|
|View VRML Call Transcripts - NASDAQ||View VRML Breaking News & Analysis - Seeking Alpha|
|View VRML Annual Report - CompanySpotlight.com||View VRML OTC Short Report - OTCShortReport.com|
|View VRML Fundamentals - TradeKing||View VRML SEC Filings - Bar Chart|
|View Historical Prices for VRML - The WSJ||View Performance/Total Return for VRML - Morningstar|
|View the Analyst Estimates for VRML - MarketWatch||View the Earnings History for VRML - CNBC|
|View the VRML Earnings - StockMarketWatch||View VRML Buy or Sell Recommendations - MacroAxis|
|View the VRML Bullish Patterns - American Bulls||View VRML Short Pain Metrics - ShortPainBot.com|
|View VRML Stock Mentions - StockTwits||View VRML Stock Mentions - PennyStockTweets|
|View VRML Stock Mentions - Twitter||View VRML Investment Forum News - Investor Hub|
|View VRML Stock Mentions - Yahoo! Message Board||View VRML Stock Mentions - Seeking Alpha|
|View Insider Transactions for VRML - SECform4.com||View Insider Transactions for VRML - Insider Cow|
|View VRML Major Holdings Summary - CNBC||View Insider Disclosure for VRML - OTC Markets|
|View Insider Transactions for VRML - Yahoo! Finance||View Institutional Holdings for VRML - NASDAQ|
|View VRML Stock Insight & Charts - FinViz.com||View VRML Investment Charts - StockCharts.com|
|View VRML Stock Overview & Charts - BarChart||View VRML User Generated Charts - Trading View|
Vermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell
Posted on Thursday September 06, 2018
“September is an opportunity for us to reach more women and raise awareness around ovarian cancer,” said Valerie Palmieri, President and CEO of Vermillion, Inc. “We are working every day to change the status quo and lead the charge in better, and earlier, detection of ovarian cancer. Vermillion’s proprietary technologies, OVA1®, and Overa are FDA-cleared blood tests to evaluate cancer risk in a pelvic mass, helping healthcare providers and women assess risk prior to surgery. It is well documented that women with high risk of cancer can improve their survival rate by up to 40% by getting to a gynecologic oncologist for the first surgery and today 2/3 of women do not use the right specialist.
Edited Transcript of VRML earnings conference call or presentation 9-Aug-18 8:30pm GMT
Posted on Tuesday August 28, 2018
Q2 2018 Vermillion Inc Earnings Call
Vermillion, Inc. Appoints Nancy Cocozza to its Board of Directors
Posted on Tuesday August 21, 2018
Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced the appointment of Nancy G. Cocozza to its Board of Directors. Ms. Cocozza joins the Board effective August 17, 2018, and brings the Board composition to six members. “We warmly welcome Nancy to our Board,” said Valerie Palmieri, President and CEO of Vermillion. “Nancy will be a tremendous asset to us, as she brings over three decades of managed care leadership and reimbursement experience.
Vermillion: 2Q Earnings Snapshot
Posted on Thursday August 09, 2018
The Austin, Texas-based company said it had a loss of 4 cents per share. The diagnostic and bio-analytical company posted revenue of $708,000 in the period. In the final minutes of trading on Thursday, ...